Today's top medical abstracts
Rheumatology
5 min a day to stay current
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Rheumatology
For Practicing
Rheumatologists
Conferences
Jobs
Newsletters
My Library
Topics in
Rheumatology
        Amyloidosis
        Autoimmune/Heritable
        Basic Science/Genetics
        Bone Metabolism
        Chr Fatigue/Fibromyalgia
        Clinical Pharmacology
        Connective Tissue Dz
        Diagnostics/Radiology
        Economics of Medicine
        Gout and Hyperuricemia
        Infectious Arthritis
        Osteoarthritis
        Other Arthritis
        Pediatric Rheumatology
        Popular Press
        Rheumatoid Arthritis
        Spondylarthropathies
        Systemic Lupus (SLE)
        Vasculitic Syndromes
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Sponsor
Sponsor
For Practicing Rheumatologists
Today's Rheumatology News: Breastfeeding Reduces The Risk Of RA
D Scott Cunningham MD, PhD, MDLinx Rheumatology
Today's Rheumatology News: SNPs Linked To Osteoporosis Risk
D Scott Cunningham MD, PhD, MDLinx Rheumatology
  See all

osteoarthritis of the knee;analgesia useArticle Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Patient reported outcomes and analgesia use in osteoarthritis of the knee
Osteoarthritis and Cartilage , 05/09/08
Print     Email This Article     Save in My Library   Free Abstract
Mody S et al. - Greater age and worse physical function and health-related quality of life (HRQoL), but not pain severity, are predictive of non-opioid analgesics (NOA) use in symptomatic knee OA. Thus pain is not the primary determinant of NOA use over time among OA patients.

Methods
  • Relationship of pain, physical function, and HRQoL to NOA use in symptomatic knee OA was assessed
  • NOA dose, pain, physical function, and HRQoL were evaluated for 1 yr
  • Doses provided by subjects' were normalized to equi-analgesic ibuprofen-equivalents (IEs)
  • Descriptive analyses at baseline, 1.5, and 12 mos
  • Non-parametric comparisons of NOA with pain, physical function, and HRQoL at 1.5 mos and over 12 mos

Results
  • 71 subjects (19 males, 52 females; mean age:57 ± 10.5 yrs) used an average of 300 mg/wk of IE
  • 25 subjects reported no analgesic use during the study
  • Of the 46 subjects that reported NOA use, the median intake was 1325 mg/wk IE
  • Age, Physical Functioning (PF) and HRQoL were predictive of NOA dose
  • Pain level was not predictive of NOA dose
  • The median NOA dose declined over 12 mos
  • However, this change was not associated with changes in PF, HRQoL or pain


 

Sponsor
--- OSTEOARTHRITIS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.